News

PBOA Praises Congressional Action On FDA Reauthorization

HELP, E&C release discussion draft of User Fees Reauthorization

Read the full news article

PBOA Commends Nomination of Dr. Scott Gottlieb for FDA Commissioner

March 13, 2017 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA) applauds the nomination of Dr. Scott Gottlieb to lead the Food and Drug Administration. PBOA President Gil Roth remarked, “Dr. Gottlieb brings a wealth of knowledge and perspective about the healthcare system, the structure and processes of the FDA, and the.

Read the full news article

PBOA Statement on Reauthorization of GDUFA

The Pharma & Biopharma Outsourcing Association (PBOA) lauded the news that the Food and Drug Administration (FDA) and industry have reached agreement on reauthorization of the Generic Drug User Fee Amendments (GDUFA) for a new five-year period, covering FY2018 to FY2022. PBOA was one of several industry groups that participated in GDUFA reauthorization negotiation sessions..

Read the full news article

PBOA Welcomes Groupe PARIMA

Quebec-based CDMO joins industry association

Read the full news article